SCHEMBL1661524

SCHEMBL1661524

[CH2]C(C)NCCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179403 0.80
SCHEMBL8369782 0.78
Hydrochloric Acid SCHEMBL5595901 0.78 ECE1 (0.42)
SCHEMBL5965366 0.76
SCHEMBL88209 0.76 CYP1A2 (0.44)
SCHEMBL919394 0.76
SCHEMBL3713828 0.76 CYP1A2 (0.44)
SCHEMBL15047670 0.76 CYP1A2 (0.40)
SCHEMBL29953253 0.76 SLC6A2 (0.41)
SCHEMBL23513804 0.74 KDM4E (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2306994-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF Amgen, Inc (US) 2011-04-13 EP disclosed
WO-2009154775-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. (US) 2009-12-23 WO disclosed